Loading...
OTCM
DSFIY
Market cap23bUSD
Jun 18, Last price  
8.84USD
1D
3.63%
1Q
31.74%
IPO
-18.19%
Name

DSM-Firmenich AG

Chart & Performance

D1W1MN
OTCM:DSFIY chart
P/E
8.18
P/S
0.16
EPS
0.94
Div Yield, %
Shrs. gr., 5y
8.40%
Rev. gr., 5y
9.86%
Revenues
12.80b
+20.44%
8,858,000,0007,051,000,0007,722,000,0007,920,000,0008,632,000,0009,267,000,0007,998,000,0008,106,000,00011,444,000,0008,390,000,00010,627,000,00012,799,000,000
Net income
250m
P
252,000,000123,000,000174,000,000645,000,0001,761,000,0001,069,000,000675,000,000448,000,000872,000,000460,000,000-652,000,000250,000,000
CFO
1.78b
+40.55%
998,000,000808,000,000696,000,0001,018,000,000996,000,0001,391,000,0001,385,000,0001,494,000,0001,427,000,000923,000,0001,265,000,0001,778,000,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

DSM-Firmenich AG is a science-driven enterprise that specializes in developing solutions for the beauty, health, and nutrition sectors. Its extensive global operations span numerous regions, including the Netherlands, Switzerland, wider Europe, North America, Latin America, China, other Asian territories, and international markets. The company's activities are organized into four primary divisions: Perfumery & Beauty: This segment is dedicated to the creation and supply of components for fragrances and other aromatic products. Animal Nutrition & Health (ANH): This division furnishes vital inputs such as vitamins, premixes, and carotenoids, as well as advanced performance-enhancing offerings like enzymes, microbes, and eubiotics. It also delivers sophisticated services, offering data-driven insights for assessing animal well-being and environmental footprint at the farm level, ensuring feed safety, and pioneering feed additives designed to diminish methane emissions from ruminants. Health, Nutrition & Care (HNC): Catering to a broad spectrum of industries, this segment provides solutions for early life nutrition, dietary supplements, pharmaceuticals, medical nutrition, personal care, and biomedical materials. Its comprehensive product range includes vitamins, specialized lipids, minerals, carotenoids, nutraceuticals, digestive enzymes, probiotics, prebiotics, active pharmaceutical ingredients, and sunscreen filters, along with various biomedical solutions. Additionally, it offers services such such as premix formulations, market-ready solutions, personalized nutrition programs, regulatory affairs support, and customized formulation expertise. Food & Beverage: This segment is responsible for developing and supplying a diverse array of ingredients and solutions used in numerous food product categories. These include dairy, baked goods, cereals, snack bars, savory items, beverages (including brewing applications), confectionery, fruit-based products, plant-based alternatives for meat and fish, and pet food. Founded in 1902, DSM-Firmenich AG's corporate headquarters are situated in Kaiseraugst, Switzerland.
IPO date
Apr 18, 2023
Employees
29,306
Domiciled in
CH
Incorporated in
CH

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT